R21/Matrix-M Malaria Vaccine: W.H.O Calls For More Trials.
Plus TV
The World Health Organisation (WHO) on Tuesday stated that the R21/Matrix-M malaria vaccine given provisional approval by the National Agency for Food and Drug Administration and Control (NAFDAC) still needs to undergo more trials.